TERMINUS.
COMPOUNDS / COFACTORS AND METABOLITES

glutathione

Cofactors and metabolites · 1 supplier · $0.05 per mg · 269 registered studies · 207,363 indexed papers

This page holds two records that were compiled separately. The research figures below come from the public registries named under each one, each read on the date printed beside it. The supplier prices at the foot were read on the suppliers own sites on the dates in that table. Nothing here was produced by this publication measuring anything.

Identity and computed properties

PubChem holds this compound as CID 124886, molecular formula C10H17N3O6S, average mass 307.33 daltons and monoisotopic mass 307.0838 daltons, read on 2026-09-19. Those masses are computed from the deposited structure and were not measured on any material, so they are the expected value an identity check compares against rather than evidence about any vial.

The title that record carries for the CID is Glutathione. Its synonym list runs to 216 entries.

Receptors the literature describes

No published paper this search reached describes a receptor this compound acts at.

The registered trial record

An intervention search of clinicaltrials.gov for the term glutathione, read on 2026-09-19, returned 269 registered studies: 6 early phase 1, 41 phase 1, 68 phase 2, 28 phase 3, 11 phase 4 and 130 recorded with no phase.

Baylor College of Medicine is lead sponsor on 9 of the 269 records. The remaining 260 name 191 other organizations.

On the date read, the statuses those records carried were 153 completed, 38 unknown and 22 recruiting, among others.

The earliest record the search returns is NCT00003793, first submitted 1999-11-01. That date is a floor, not an origin: earlier work may sit in the registry under a code number this search term does not match.

Registry counts measure registration, not knowledge.

The publication record

PubMed answered 207,363 records for the term glutathione on 2026-09-19. Of those, 3,209 carry a clinical-trial publication type, and 31 of those carry Clinical Trial, Phase III. 11,535 carry the publication type Review, which is other people reading the rest.

PubMed counts measure indexing, so work in venues it does not index is invisible to this figure. The term that produced it is printed above so it can be run again.

Regulatory status

The Drugs@FDA database holds application NDA 018469 under this name, sponsor ALCON. Its listed product is marked Prescription in the same database.

Findings, as published reports recorded them

This block was compiled and no finding from a named publication was reached.

Adverse events, as published reports recorded them

This block was compiled and no adverse event from a named publication was reached.

Spontaneous report databases are not used on this page. A count of reports carries no denominator, so it cannot be read as a rate and is not printed as one.

Who it is not given to

An approved product carrying this name is on the Food and Drug Administration record, read 2026-09-19. Its label is the only official list of who must not be given it, and that label has not been read for this page. Nothing here should be treated as that list.

Every row is a price read on that supplier's own site, divided by the milligrams it buys. Cheapest first, which is not a ranking of quality: the columns beside the rate show what this publication could confirm about the evidence behind it. Some supplier links here are referral links, marked where they appear, which pay Terminus Research when a reader buys. The same terms are open to every supplier in the ledger, apart from the one exception the referral policy page names, participation changes no score, rank, caution, or coverage decision, and a link is not an endorsement.

Vendor comparison

Per mgPriceSupplierCertificate checkableCaution on recordWhat the figure is
$0.05per mg $79.001500mg Prime Labsrecord → not transcribed not transcribed single vial current price from catalog dataread 2026-08-26

Read between 2026-08-26 and 2026-08-26. Prices move and these were read once.

Sources

Registered study counts, phases, lead sponsors and first-submitted dates: the clinicaltrials.gov public API, one intervention search on the term printed above, read 2026-09-19. Indexed paper counts and publication types: PubMed, the term printed above and that term narrowed by publication type, read 2026-09-19. Formula and computed mass: PubChem, the CID printed above, read 2026-09-19. Application status: the Food and Drug Administration Drugs@FDA database through the agency public endpoint, read 2026-09-19.

The dates in the paragraph above are the dates those fetches ran, stamped in UTC. The dates in the list below are the dates a person read each record. The same record can carry both, a day apart, when a fetch ran after midnight UTC.

ALL COMPOUNDS